PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-Jun-2022 Digital Therapeutics Users to Exceed 40 Million in the US by 2026, as Omada Health Tops Juniper Research Competitor Leaderboard Juniper Research
07-Jun-2022 Sanofi launches 2022 global Employee Stock Purchase Plan for 86.000 people Sanofi
07-Jun-2022 Almirall: Eight out of Ten Patients Maintained Skin Clearance at One Year in Lebrikizumab Atopic Dermatitis Monotherapy Trials Almirall
07-Jun-2022 AnHeart Therapeutics and Innovent Biologics Present Updated Phase 2 Efficacy and Safety Data of Taletrectinib (ROS1 Inhibitor) at ASCO 2022 AnHeart Therapeutics
07-Jun-2022 Santhera Announces Corporate Calendar Update Santhera Pharmaceuticals
07-Jun-2022 Santhera Announces Improved Liquidity Position Santhera Pharmaceuticals
07-Jun-2022 Arbutus and Vaccitech Dose First Patient in Phase 2a Clinical Trial Combining Therapies for the Treatment of Chronic Hepatitis B Virus Arbutus Biopharma Corporation
07-Jun-2022 Tiziana Life Sciences to Present at the 2022 Biotechnology Innovation Organization Annual Convention to Discuss Recent Updates to Ongoing Clinical Programs Tiziana Life Sciences
07-Jun-2022 Immutep reports positive Overall Response Rate in its Phase II clinical trial in first line NSCLC for PD-L1 all-comers Immutep
07-Jun-2022 Microbiota Transplantation Demonstrates How Gut Bacteria Contributes to Weight Loss and Beneficial Metabolic Effects with Gelesis’ Proprietary Hydrogel Gelesis
07-Jun-2022 Innovative Trials to help fund research into multiple sclerosis through charity partnership Innovative Trials
07-Jun-2022 Nouscom Announces Positive Phase 1 Data of NOUS-209, an ‘off-the-shelf’ Neoantigen Cancer Immunotherapy for the Treatment of dMMR / MSI-H Solid Tumors, at ASCO 2022 Nouscom
07-Jun-2022 Transgene Presented Additional Phase I Data with TG4050 (myvac® platform) at ASCO 2022 Transgene
07-Jun-2022 Enterome presents proof-of-concept immune response data and first clinical data from Phase 1/2 trial with EO2401, a first-in-class OncoMimics™ therapeutic cancer vaccine for glioblastoma, at ASCO 2022 Enterome
07-Jun-2022 BC Platforms Drives Data Enablement and Collaboration to Accelerate Precision Medicine in Asia BC Platforms
07-Jun-2022 DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value DFE Pharma
07-Jun-2022 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
07-Jun-2022 Longer-term Data from CARTITUDE-1 Study Demonstrate Continued Deep and Durable Responses to CARVYKTI™ (ciltacabtagene autoleucel) in Heavily Pretreated Patients with Relapsed or Refractory Multiple Myeloma Janssen
07-Jun-2022 Drug combination shows promise against cancer’s ‘death star’ protein The Institute of Cancer Research
07-Jun-2022 Coriolis Pharma Invests in Growth by Creating a New Campus in Martinsried-Munich Coriolis Pharma